Inactive Instrument

EKIMAS Corporation Share Price Other OTC

ASNB

US28265K1060

Latest news : EKIMAS Corporation

15/07	Tranche Update on Nordicus Partners Corporation's Equity Buyback Plan announced on November 14, 2025.	CI
15/07	Nordicus Partners Corporation Reports Earnings Results for the Full Year Ended March 31, 2026	CI
14/07	Nordicus Partners Corporation Auditor Raises 'Going Concern' Doubt	CI
13/07	Nordicus Partners Corporation Announces Resignation of Andrew J. Ritter from Director and Board Committee Roles, Effective July 7, 2026	CI
30/04	Nordicus Partners Corporation announced that it has received $0.554125 million in funding	CI
31/03	Nordicus Partners Corporation announced that it expects to receive $0.554125 million in funding	CI
14/02	Tranche Update on Nordicus Partners Corporation's Equity Buyback Plan announced on November 14, 2025.	CI
14/02	Nordicus Partners Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
04/02	Nordicus Partners Corporation Announces Establishment of Board Committees	CI
06/12	Nordicus Partners Corporation announced that it has received $1.144 million in funding	CI
14/11	Nordicus Partners Corporation announces an Equity Buyback for 200,000 shares.	CI
14/11	Tranche Update on Nordicus Partners Corporation's Equity Buyback Plan announced on November 14, 2025.	CI
14/11	Nordicus Partners Corporation Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI

More news

Press Releases: EKIMAS Corporation

15/06	Nordicus Partners Corporation Corporate Update	AQ
06/02	Nordicus Partners Corporation Corporate Update	AQ
13/11	NoviThera has initiated the first efficacy animal studies	AQ
22/25/22	Orocidin’s QR-01 Shows Positive Results in Treating Periodontitis in the treatment of experimental periodontitis in Wistar rats.	AQ
20/25/20	Orocidin develops novel cGMP manufacturing process in collaboration with Syngene	AQ

More press releases

Ekimas Corp is engaged in identifying an operating company or acquire or merge with through an equity-based exchange transaction or investor interested in purchasing a majority interest in its common stock, whereby either transaction would result in a change in control. The Company has no operations.

Employees

Sector

More about the company

Market Cap	3.74Cr 3.24Cr 3.04Cr 2.77Cr 5.21Cr 356.98Cr 5.3Cr 36Cr 14Cr 178.68Cr 14Cr 14Cr 596.11Cr	P/E 2025	-15.1x	P/E 2026	-14.7x
Enterprise Value	3.75Cr 3.25Cr 3.04Cr 2.77Cr 5.22Cr 357.36Cr 5.31Cr 36Cr 14Cr 178.87Cr 14Cr 14Cr 596.73Cr	EV / Sales 2025	16,36,44,56,400x	EV / Sales 2026	-
Free-Float	-	Yield 2025 *	-	Yield 2026	-

	2025	2026
Net sales	0 0 0 0 0.01 0.48 0.01 0.05 0.02 0.24 0.02 0.02 0.8	-
Net income	-29.01L -25.14L -23.54L -21.48L -40.42L -28Cr -41.09L -2.76Cr -1.08Cr -14Cr -1.09Cr -1.07Cr -46Cr	-40.02L -34.68L -32.46L -29.62L -55.74L -38Cr -56.68L -3.81Cr -1.49Cr -19Cr -1.5Cr -1.47Cr -64Cr
Net Debt	-19.91T -17.26T -16.16T -14.74T -27.74T -18.99L -28.21T -2L -74.22T -10L -74.77T -73.14T -31.72L	39.12T 33.9T 31.74T 28.96T 54.5T 37.31L 55.41T 4L 1L 18.68L 1L 1L 62.31L

EKIMAS Corporation Share Price Other OTC

Stocks

ASNB

US28265K1060

Valuation: EKIMAS Corporation

Latest news : EKIMAS Corporation

Press Releases: EKIMAS Corporation

Quotes and Performance

Financials

Company Profile